Imricor Medical Systems Inc (ASX: IMR) Share Price and News

Price

$1.695

Movement

0.005 (-0.29%)

as at 12 May - Closed (20 mins delayed)

52 Week Range

$0.41 - $1.855

 
1 Year Return

+272.53%

Imricor Medical Systems Inc Chart and Price Data

2025
2025
2025
2025
$0
$1
$2
$0
$1
$2
$0
$1
$2
$0
$1
$2

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $544.55 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 320.33 million
Earnings per share -0.130
Dividend per share N/A
Year To Date Return 25.00%
Earnings Yield N/A
Franking -
Share Price

$1.695

Day Change

0.005 (-0.29%)

52 Week Range

$0.41 - $1.855

Yesterday's Close

$1.70

Today's Open

$1.72

Days Range

$1.62 - $1.72

Volume

189,463

Avg. Volume (1 month)

415,024

Turnover

$318,233

as at 12 May - Closed

Imricor Medical Systems Inc (ASX: IMR)
Latest News

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Imricor, Nanosonics, Perpetual, and Tourism Holdings shares are sinking today

These shares are having a tough finish to the week. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Market News

Why Antipa, Imricor, Lynas, and Newmont shares are pushing higher today

These shares are ending the week on a high. But why?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Up 200% in a year! Why is this ASX healthcare stock rocketing today?

This stock just can't stop rising. What is it this time?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Brainchip, Imricor, Strike Energy, and Wildcat shares are rising today

Why are these shares starting the week strongly? Let's find out.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Share Gainers

Why Imricor, Maas, Resolute Mining, and Select Harvests shares are charging higher

These shares are ending the week in a positive fashion. Here's what is happening.

Read more »

A beautiful woman holds up one finger with one hand and has her hand on her waist with the other as she smiles widely as though she is very pleased about something.
Share Gainers

Why DroneShield, Imricor, IAG, and Sayona Mining shares are roaring higher

These shares are making investors smile on Thursday. Why are they rising?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Market News

ASX healthcare stock rockets 25% on big AI news

This medical device company is aiming to make its offering an indispensable central hub.

Read more »

Doctor looking serious with arms crossed
Healthcare Shares

Here's why the Imricor Medical (ASX:IMR) share price is surging 8% today

What did the company update the ASX with?

Read more »

male wearing face mask reviewing medical scans on light box
Healthcare Shares

Imricor Medical (ASX:IMR) share price spikes 6% after expanding trial sites

The vascular catheter specialist share price having a great Friday.

Read more »

share price up
Share Market News

Why the Imricor (ASX:IMR) share price is racing 6% higher today

The company is pushing ahead with its strategy...

Read more »

Young doctor raising arms in air with hands in fists celebrating a new development
Healthcare Shares

Imricor (ASX:IMR) share price rises on latest update

The Imricor Medical Systems Inc (ASX: IMR) share price is edging higher today after news another hospital has purchased one…

Read more »

medical asx share price represented by doctor giving thumbs up
Share Market News

Why the Imricor (ASX:IMR) share price is edging higher today

The Imricor Medical Systems Inc. (ASX: IMR) share price is edging higher today following two major announcements.

Read more »

IMR ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
5th May 2025 2025-05-05T16:57:47 Release from Voluntary EscrowYesNo4:57pm2230k
1st May 2025 2025-05-01T08:58:35 Procedures Commence at Semmelweis UniversityYesNo8:58am2238k
23rd Apr 2025 2025-04-23T10:19:46 Imricor Q1 CY25 Quarterly Activities Report and Appendix 4CYesNo10:19am10702k
17th Apr 2025 2025-04-17T08:53:58 CE Mark Approval for Advantage-MR under EU's MDRYesNo8:53am2241k
16th Apr 2025 2025-04-16T16:49:04 Change in substantial holding from CGFYesNo4:49pm6334k
16th Apr 2025 2025-04-16T16:20:19 Change in substantial holdingYesNo4:20pm4251k
14th Apr 2025 2025-04-14T11:15:14 Notification regarding unquoted securities - IMRYesNo11:15am616k
11th Apr 2025 2025-04-11T08:40:20 Imricor Commences VISABL-VT Clinical TrialYesNo8:40am2239k
10th Apr 2025 2025-04-10T16:53:21 Notice of Annual Stockholders Meeting and CDI Voting FormYesNo4:53pm391.2M
10th Apr 2025 2025-04-10T16:47:46 Appendix 4G and Corporate Governance StatementYesNo4:47pm24521k

About Imricor Medical Systems Inc

Imricor Medical Systems Inc is a medical device company that develops MRI-guided technology to address issues with traditional X-ray ablation procedures. Its principal business activities are designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The company's products include the Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter, and Vision-MR Dispersive Electrode. Geographically, the company generates maximum revenue from Europe, followed by the Middle East and the United States.

IMR Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
09 May 2025 $1.70 $-0.08 -4.51% 182,890 $1.83 $1.83 $1.70
08 May 2025 $1.78 $0.08 4.71% 403,610 $1.73 $1.84 $1.72
07 May 2025 $1.70 $0.00 0.00% 487,030 $1.70 $1.71 $1.68
06 May 2025 $1.70 $-0.04 -2.30% 491,695 $1.73 $1.75 $1.66
05 May 2025 $1.74 $-0.02 -1.13% 726,647 $1.82 $1.86 $1.68
02 May 2025 $1.77 $0.08 4.75% 313,285 $1.66 $1.80 $1.63
01 May 2025 $1.69 $0.07 4.32% 191,764 $1.69 $1.71 $1.61
30 Apr 2025 $1.62 $0.00 0.00% 540,708 $1.64 $1.71 $1.61
29 Apr 2025 $1.63 $0.04 2.52% 134,938 $1.59 $1.63 $1.56
28 Apr 2025 $1.59 $-0.02 -1.25% 619,963 $1.60 $1.60 $1.49
24 Apr 2025 $1.61 $0.10 6.62% 387,090 $1.52 $1.65 $1.51
23 Apr 2025 $1.51 $0.11 7.86% 494,661 $1.42 $1.52 $1.42
22 Apr 2025 $1.40 $-0.07 -4.76% 413,281 $1.45 $1.46 $1.38
17 Apr 2025 $1.47 $0.01 0.69% 501,587 $1.46 $1.47 $1.37
16 Apr 2025 $1.46 $-0.01 -0.68% 232,610 $1.51 $1.51 $1.42
15 Apr 2025 $1.47 $0.06 4.26% 509,853 $1.43 $1.48 $1.38
14 Apr 2025 $1.41 $-0.06 -4.08% 423,789 $1.55 $1.55 $1.40

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
06 Jun 2024 Steve Wedan Issued 2,113,342 $951,003
Issue of options.
22 May 2024 Steve Wedan Buy 100,000 $45,000
Off-market trade. CDIs
21 May 2024 Peter McGregor Issued 107,556 $47,862
Issue of securities. CDI
21 May 2024 Mark Tibbles Issued 107,556 $47,862
Issue of securities. CDIs
21 May 2024 Anita Messal Issued 100,834 $44,871
Issue of securities.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Peter McGregor Non-Executive Director May 2019
Mr McGregor has over 30 years of experience in senior finance and management roles, including having been a partner in the investment banking firm of Goldman Sachs JBWere and a managing director in the institutional banking & markets division of Commonwealth Bank of Australia. Mr McGregor is an experienced company director, and currently serves as a Director of Treasury Corporation of Victoria and Green Eco International Limited, and is a former director of TRUE Infrastructure Management Pty Ltd, and the Brisbane Lions Australian Football Club. He is chair of the Risk Committee.
Mr Steve Wedan Chief Executive OfficerPresidentExecutive ChairmanExecutive Director May 2006
Mr Wedan has over 30 years of experience in the medical device industry including design engineering of MRI and ultrasound systems for GE Healthcare, as well as Vice President and Chief Technology Officer for Applied Biometrics Inc. Immediately prior to co-founding Imricor, Mr Wedan founded and operated a technical consulting company, Wedan Technologies Inc., from 2000-2006. Mr Wedan is a member of international standards committees in the fields of MRI safety and the compatibility of implanted and interventional products in MRI. Mr Wedan currently serves on the Board of Directors of Medical Device Research Forum, Inc. and Water Rescue Innovations, Inc., as well as the Advisory Board of Poiesis Medical, LLC.
Mr Mark Tibbles Non-Executive Deputy ChairmanNon-Executive Director Sep 2014
Mr Tibbles is an entrepreneur, business owner, company director and active venture investor in and advisor to technology, life science and medical device companies. Mr Tibbles is currently a Board member of FamGenix, and CorVent Medical, Inc.; Co-Founder and Board member of PERMnet, Inc.; an owner and managing member of STEM Fuse, LLC, one of the providers of digital K-12 STEM curriculum in the U.S.; and the Managing Director of Strategic Stage Ventures, LLC. Prior to his current roles, Mr Tibbles was a Board member of the Nerdery, LLC as well as an owner and member of Intuitive Technology Group until it was sold in 2017. Mr Tibbles was also a President and founder of PRC Consulting, Inc., a company in the management and implementation of IT projects for Fortune 1000 Companies, from 1998 until 2013, when PRC was sold. He is member of the Risk Committee.
Ms Anita Messal Non-Executive Director Mar 2021
Ms Messal is an executive with 40 years of accomplishments across a variety of functions. With a career in healthcare and benefits, she has experience in health plan services, health care delivery, care management, and benefits administration. Ms Messal has experience in public, private, and non-profit sectors, working in both domestic and international markets. She has led areas of company performance, including sales, product, operations, and technology. Her responsibilities have encompassed M&A integration, data exchange, account management, customer service, system development, information security, product development, national accounts, project management, vendor management, strategic systems, legal, human resources, and learning & development. Ms Messal has also played a role in fundraising from start-up through IPO and sale to strategic buyers and private equity. Ms Messal currently serves on the Board of Directors of Ideon as Executive Chair and is an Advisor to Poiesis Medical. She is member of the Risk Committee.
Mr Jeffrey Leighton Non-Executive Director Jul 2024
Dr Leighton is a cognitive neuroscientist with experience in both academic and corporate settings. He has a robust research, teaching, and leadership background. Dr Leighton has business acumen as CFO at NDS Wellness, a regional (23 states) provider of mobile neuroimaging and wellness centers. He was in the company's growth phase, managing financial operations and working with the CEO. NDS Wellness offered comprehensive services, including mobile wellness clinics, telehealth, and health screenings, to corporations and self-insured companies. Dr Leighton has held key corporate governance and advisory roles, including serving as an Institutional Review Board (IRB) member at a non-profit neuromodulatory research center.
Mr Kobe Li Company Secretary
-
Gregg Stenzel Chief Operating Officer
-
Kobe Li Company Secretary
-
Nick Corkill Vice President Corporate Strategy
-
Kate Lindborg Vice President of Clinical Affairs
-
Jonathon Gut Vice President of Finance and Chief Financial Officer
-
Greg Englehardt Vice President of Global Sales
-
Nick Twohy Vice President of Marketing and Business Development
-
Vic Fabano Vice President of Operations
-
Jennifer Weisz Vice President of Regulatory and Quality
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Citicorp Nominees Pty Limited <Domestic Hin A/C> 56,359,497 17.59%
HSBC Custody Nominees (Australia) Limited 44,330,815 13.84%
BNP Paribas Noms (Nz) Ltd 17,075,876 5.33%
J P Morgan Nominees Australia Pty Limited 15,569,712 4.86%
Argo Investments Limited 11,238,407 3.51%
Warren G Herreid Ii 9,486,098 2.96%
Siemens Medical Solutions Usa Inc 8,384,150 2.62%
UBS Nominees Pty Ltd 7,742,928 2.42%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 7,409,555 2.31%
HR Global Investments Llc 6,879,579 2.15%
HSBC Custody Nominees (Australia) Limited A/C 2 5,680,400 1.77%
Kahr Foundation 2,950,988 0.92%
Mr Grant Bruce Byron Taylor and Mr Keith Robert Taylor <Sorrento A/C> 2,732,000 0.85%
Steven R Wedan 2,693,720 0.84%
Maclay Group Pty Ltd <Maclay Longhurst Family A/C> 2,662,178 0.83%
Mr Kenneth Joseph Hall <Hall Park A/C> 1,923,077 0.60%
Pounamu Capital Pty Limited 1,923,077 0.60%
BNP Paribas Noms Pty Ltd 1,862,834 0.58%
Merrill Lynch (Australia) Nominees Pty Limited 1,813,512 0.57%
Bauer Private Equity Fund Vi Llc 1,696,555 0.53%

Profile

since

Note